These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24081111)

  • 1. High frequency of varicella zoster virus reactivation associated with the use of arsenic trioxide in patients with acute promyelocytic leukemia.
    Yamakura M; Tsuda K; Ugai T; Sugihara H; Nisihida Y; Takeuchi M; Matsue K
    Acta Haematol; 2014; 131(2):76-7. PubMed ID: 24081111
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes zoster during treatment with arsenic trioxide.
    Lanska DJ
    Ann Hematol; 2004 Jun; 83(6):408. PubMed ID: 15034759
    [No Abstract]   [Full Text] [Related]  

  • 3. Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia.
    Au WY; Hon C; Yau K; Lai WW; Fong BM; Tam S; Kwong YL
    Am J Hematol; 2009 Oct; 84(10):699. PubMed ID: 19705432
    [No Abstract]   [Full Text] [Related]  

  • 4. Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy.
    Glass JL; Derkach A; Hilden P; King A; Seo SK; Ahr K; Kishtagari A; Levine RL; Tallman MS; Douer D
    Leuk Res; 2021 Jul; 106():106569. PubMed ID: 33857746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent varicella zoster reactivation associated with therapeutic use of arsenic trioxide: portents of an old scourge.
    Au WY; Kwong YL
    J Am Acad Dermatol; 2005 Nov; 53(5):890-2. PubMed ID: 16243151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in management of acute promyelocytic leukemia with arsenic trioxide.
    Ma J
    Chin J Integr Med; 2007 Jun; 13(2):92-4. PubMed ID: 17609904
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-lethal bone marrow necrosis under first-line arsenic trioxide therapy in acute promyelocytic leukaemia.
    Ianotto JC; Tempescul A; Eveillard JR; Charles F; Berthou C
    Acta Haematol; 2010; 123(3):146-7. PubMed ID: 20134156
    [No Abstract]   [Full Text] [Related]  

  • 8. Herpes zoster during treatment with arsenic trioxide.
    Tanvetyanon T; Nand S
    Ann Hematol; 2004 Mar; 83(3):198-200. PubMed ID: 15064871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of recurrent herpes simplex and herpes zoster infection during treatment with arsenic trioxide.
    Nouri K; Ricotti CA; Bouzari N; Chen H; Ahn E; Bach A
    J Drugs Dermatol; 2006 Feb; 5(2):182-5. PubMed ID: 16485889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia complicated by massive intracerebral hemorrhage: safety and efficacy of replacing conventional chemotherapy with arsenic trioxide in an adolescent.
    Müller E; Seidel MG; Lackner H; Dworzak M; Urban C
    Klin Padiatr; 2013 May; 225(3):172-3. PubMed ID: 23625686
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide.
    Yujiri T; Tanaka M; Taguchi A; Tanaka Y; Nakamura Y; Tanizawa Y
    Ann Hematol; 2014 Feb; 93(2):351-2. PubMed ID: 23728611
    [No Abstract]   [Full Text] [Related]  

  • 12. Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.
    Chen Z; Zhao WL; Shen ZX; Li JM; Chen SJ; Zhu J; Lallemand-Breittenbach V; Zhou J; Guillemin MC; Vitoux D; de Thé H
    Curr Top Microbiol Immunol; 2007; 313():129-44. PubMed ID: 17217042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide for the treatment of a relapsed acute promyelocytic leukemia with acute renal failure.
    Yoon HS; Park TS; Jeong KH
    Pediatr Blood Cancer; 2011 Dec; 57(6):1085. PubMed ID: 21656902
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Novoseven for arsenic trioxide-induced bleeding in PML.
    Alimoghaddam K; Ghavamzadeh A; Jahani M
    Am J Hematol; 2006 Sep; 81(9):720. PubMed ID: 16804937
    [No Abstract]   [Full Text] [Related]  

  • 15. Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.
    Fukushima T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Masaki Y; Okazaki T; Nakajima H; Motoo Y; Umehara H
    Anticancer Res; 2012 Dec; 32(12):5437-40. PubMed ID: 23225448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity in African-American patients treated with arsenic trioxide for acute promyelocytic leukemia.
    Patel SP; Garcia-Manero G; Ferrajoli A; Faderl S; Verstovek S; Kantarjian H; Estey E
    Leuk Res; 2006 Mar; 30(3):362-3. PubMed ID: 16168477
    [No Abstract]   [Full Text] [Related]  

  • 17. [Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].
    Lengfelder E; Schultheis B; Büchner T; Hehlmann R
    Dtsch Med Wochenschr; 2007 Feb; 132(7):330-6. PubMed ID: 17286223
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperleukocytosis from arsenic trioxide.
    Levy M; Wofford MM; Powell BL; McLean TW
    Pediatr Blood Cancer; 2008 Jun; 50(6):1265-7. PubMed ID: 18300308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia.
    Perreault S; Moeller J; Patel K; Eyler R; Pham T; Russell K; Podoltsev N
    J Oncol Pharm Pract; 2016 Aug; 22(4):646-51. PubMed ID: 25972392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased erythropoietin level and reticulocyte count during arsenic trioxide therapy.
    Kajiguchi T; Yamamoto K; Sawa M; Emi N; Naoe T
    Leukemia; 2005 Apr; 19(4):674-6. PubMed ID: 15690072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.